1309 — Taita Chemical Co Balance Sheet
0.000.00%
- TWD4.71bn
- TWD3.89bn
- TWD18.62bn
Annual balance sheet for Taita Chemical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,822 | 3,297 | 3,082 | 2,386 | 2,689 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,285 | 2,585 | 1,743 | 1,921 | 2,557 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5,942 | 7,290 | 6,007 | 5,515 | 6,505 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,155 | 2,081 | 2,029 | 2,195 | 2,188 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 9,246 | 10,745 | 9,241 | 8,891 | 9,840 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,170 | 2,343 | 1,358 | 1,921 | 3,196 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,890 | 3,083 | 2,035 | 2,243 | 3,542 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 6,356 | 7,662 | 7,206 | 6,648 | 6,298 |
Total Liabilities & Shareholders' Equity | 9,246 | 10,745 | 9,241 | 8,891 | 9,840 |
Total Common Shares Outstanding |